MFGR1877S binds to FGFR3 with a high affinity to competitively inhibit native ligand binding and prevent receptor dimerization not only in cells with wild-type FGFR3 but also in cells with the most prevalent cancer-associated mutants of FGFR3 [58]. Here, FGFR3 is linked to cancer.